Avego转发了
We are delighted to announce the successful closing of an oversubscribed Series D financing, raising $181.4M to develop a deep pipeline of CLDN1 targeted medicines for solid tumors. The funding was supported by a syndicate of top-tier biotech investors including OrbiMed as lead and Novo Holdings and JEITO as co-leads as well as substantial contributions from Frazier Life Sciences, Longitude Capital, RA Capital Management, and Catalio Capital Management. This financing is a testament to the transformational potential of CLDN1 targeted medicine in oncology, in particular our first-in-class antibody-drug conjugates (#ADCs) ALE.P02 and ALE.P03. We’re excited to start Phase 1/2 clinical trials for both programs in 2025. Read the full press release: https://lnkd.in/eVSGPG5G We extend our deepest gratitude to our investors for their trust and support. Together we are making a difference ???? #AlentisTherapeutics #Biotech #Funding #Healthcare #LifeSciences #ADC #CLDN1 #Claudin
Congratulations to Alentis Therapeutics and the entire team on your impressive Series D financing! We are thrilled to have you at Switzerland Innovation Park Basel Area Main Campus and look forward to seeing the impact of CLDN1 targeted medicines for solid tumors. Switzerland Innovation Park Basel Area - a place where you can shape the future
Huge congrats to the Alentis Therapeutics team on raising $181.4M in Series D! ?? This strong backing from OrbiMed, Novo Holdings, Jeito Capital, and others highlights the promise of your CLDN1-targeting ADCs. Excited to see ALE.P02 and ALE.P03 make waves in the fight against solid tumors, what key milestones are you most excited to achieve in the next 12-18 months? ?? ??
Superb news, Alentis Therapeutics! Huge congratulations to you, Roberto Iacone & team! We're proud that you're our resident at our Main Campus. Keep on shining!
Fantastic news! Congratulations to the entire Alentis team!
Love this
Congratulations, Alentis Therapeutics team. It's a great achievement.
Congratulations! What an amazing accomplishment for the entire Alentis team! Advyzom is so thrilled to continue to support your major regulatory milestones.
Professor of Medicine and Chair, Founder Alentis Therapeutics, Director Institute for Translational Medicine Inserm
3 个月Congratulations and very proud as the founder of Alentis !